The first shipment of Lenacapavir, a long-acting injectable that prevents HIV with two shots a year, arrived in South Africa ...
Over half of the people carrying HIV experience chronic pain at some point, which is difficult to treat. In a new JNeurosci ...
For years, researchers have been hoping for vaccines that protect people against not just one strain of HIV, but every strain ...
Arabian Post on MSN
Immuno Cure deploys scientist team to manage research facility for therapeutic DNA vaccine for HIV at Center of International Innovation for Technology and Science
Another significant step towards the success of ICVAX®HONG KONG SAR – Media OutReach Newswire – 27 May 2026 – Immuno Cure Group (“Immuno Cure“), headquartered at Hong Kong Science Park, is pleased to ...
Thank you for joining this Multi-Stakeholder Interactive Hearing in preparation for the High-Level Meeting on HIV/AIDS. Frankly speaking, I was really looking forward to this hearing… not only because ...
Every time a cell divides, it must copy its DNA with extraordinary precision. But this process is constantly challenged by DNA damage. Among the most dangerous lesions are DNA interstrand crosslinks ...
Researchers from Queen Mary University of London have uncovered a previously unknown mechanism by which HIV-1 can infect resting immune cells. The discovery challenges a decades-old assumption in HIV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results